Skip to Main content Skip to Navigation
Journal articles

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.: Impact of a loss-of-function MAVS variant on SLE

Abstract : Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous single nucleotide polymorphisms (SNPs) in the MAVS gene for functional significance in human cell lines and identified one critical loss-of-function variant (C79F, rs11905552). This SNP substantially reduced expression of type I interferon (IFN) and other proinflammatory mediators and was found almost exclusively in the African-American population. Importantly, in African-American SLE patients, the C79F allele was associated with low type I IFN production and absence of anti-RNA-binding protein autoantibodies. These serologic associations were not related to a distinct, functionally neutral, MAVS SNP Q198K. Hence, this is the first demonstration that an uncommon genetic variant in the MAVS gene has a functional impact upon the anti-viral IFN pathway in vivo in humans and is associated with a novel sub-phenotype in SLE. This study demonstrates the utility of functional data in selecting rare variants for genetic association studies, allowing for fewer comparisons requiring statistical correction and for alternate lines of evidence implicating the particular variant in disease.
Document type :
Journal articles
Complete list of metadatas

Cited literature [40 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-00562505
Contributor : Mustapha Si-Tahar <>
Submitted on : Wednesday, August 3, 2011 - 7:00:18 AM
Last modification on : Saturday, May 30, 2020 - 3:39:37 AM
Long-term archiving on: : Friday, November 4, 2011 - 2:20:06 AM

File

M._Si-Tahar.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Julien Pothlichet, Timothy Niewold, Damien Vitour, Brigitte Solhonne, Mary Crow, et al.. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.: Impact of a loss-of-function MAVS variant on SLE. EMBO Molecular Medicine, Wiley Open Access, 2011, 3 (3), pp.142-52. ⟨10.1002/emmm.201000120⟩. ⟨pasteur-00562505⟩

Share

Metrics

Record views

438

Files downloads

618